Opinion

Video

Evaluating CDK4/6 Inhibitor Safety Profiles: An Analysis of Adverse Events

A medical expert compares CDK4/6 inhibitors and discusses the importance of monitoring specific parameters, such as ECGs and laboratory tests, to minimize adverse events associated with each drug.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
1 KOL is featured in this series.
1 expert in this video
1 expert in this video